Money3 Price Target Cut 1.2% to A$2.46/Share by Canaccord Genuity.Plus ex dividend. Should recover after a few weeks.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025